logo
15:59 Dec 05

Lyka Labs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
77.43
-3.73 (-4.60%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Lyka Labs Ltd. Financials

Lyka Labs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
77.43
-3.73 (-4.60%)
15:59 Dec 05
Quality
image/svg+xml

75/100
High Financial Strength

Valuation
image/svg+xml

33/100
Mid Valuation

Technical

26/100
Technically Bearish

Strength

8

Weakness

12

Opportunity

1

Threats

0

7.73 %

ROE %

4.54 %

ROA %

0.58

EPS

29.01

BVPS

5.78 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
194.08 93.07 111.19 138.5 141.42
Operating Expenses +
92.93 76.23 95.48 120.56 123.49
Raw Material
53.39 38.77 45.63 56.95 57.75
Increase Decrease in Cost
-0.41 -1.21 -0.78 -1.36 -0.92
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
18.06 18.61 26.77 34.63 35.49
Miscellaneous Expenses
74.79 51.44 50.84 70.1 31.17
Operating Profit
101.15 16.84 15.71 17.94 17.93
Other Income
2.09 3.4 1.45 2.23 2.31
Depreciation
17.35 14.15 12.8 6.77 7.12
Interest
20.13 11.87 4.89 2.27 2.47
Profit before tax and exceptio..
65.77 -5.78 -0.52 11.12 10.65
Exceptional Items
-6.52 -7.39 -0.41 0 0
PBT
59.25 -13.17 -0.93 11.12 10.65
Provision for Taxation
20.8 -0.02 1.69 3.19 2.98
Net Profit
38.44 -13.15 -2.62 7.93 7.64
NET Profit after MI
39 -13.21 -2.49 8.01 7.51
EPS
13.57 -4.63 -0.79 2.22 2.07
Operating Profit Margin (%)
52.12 18.09 14.13 12.95 12.68
Net Profit Margin (%)
20.09 -14.19 -2.24 5.78 5.31

Lyka Labs Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 58.20 58.20 58.20 58.10 58.10 58.10
FII 0.20 0.20 0.20 0.20 0.20 0.20
Public 0.60 0.60 0.70 0.60 0.60 0.70
Others 41.00 41.00 40.90 41.10 41.10 41.00
Shareholder Shares Holding %
Research 360 logo
Download Our App On: